Details of Drug-Drug Interaction
| Drug General Information (ID: DDI4GRNBQ9) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Lanthanum carbonate | Drug Info | Ferrous fumarate | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Phosphate Binders | Iron Supplement | |||||||
| Structure | |||||||||
| Mechanism of Lanthanum carbonate-Ferrous fumarate Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Complex formation Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Lanthanum carbonate | Ferrous fumarate | |||||||
| Mechanism | Anion exchange resin/polymer | Binds to anion exchange resin/polymer | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Chelation | ||||||||
| Factor Description | Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | To minimize the potential for interaction, drugs that are known to interact with antacids (e.g., ACE inhibitors, beta blockers, bisphosphonates, coumarin derivatives, digitalis glycosides, fluoroquinolones, iron, phenytoin, rifampin, tetracyclines, thyroid preparations, valproic acid) should not be taken within 2 hours of administration of lanthanum carbonate according to the product labeling. | ||||||||

